Moderna shares jumped after the biotechnology company reported higher-than-expected sales of its Covid-19 vaccine and backed ...

Researchers investigate how public trust in the science of COVID-19 vaccines has changed in the United States.

A jury awarded more than $12 million Friday to a woman who lost her job at a Michigan insurance company after declining to ...

The Centers for Disease Control and Prevention (CDC) recommends the Moderna and Pfizer-BioNTech COVID-19 vaccines for kids as ...

Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...

In conclusion, this report presents the first known cases of TTP associated with an inactivated COVID-19 vaccine and ...

A study conducted by researchers from the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) and the ...

Older Americans are being urged to get the COVID-19 vaccine again, but it depends on when they received their last dose.

A federal judge approved a class-action settlement between Ascension and a group of employees to resolve claims that workers ...

As of late October, the CDC recommends a second dose of the 2024-2025 COVID-19 vaccine for at-risk groups. Here's what you ...

The Centers for Disease Control and Prevention's (CDC's) 2024-2025 COVID-19 vaccine immunization schedule advises, in the ...

The biotech company, which makes the Spikevax RNA-based Covid-19 vaccine, reported net income of $13 million, or 3 cents a share, compared with a loss of $3.6 billion, or $9.53 a share, in the same ...